Power Sean A's Form 4 filing
TG Therapeutics, Inc. (TGTX) · filed Jan 7, 2022
- Accession no.
- 0001104659-22-002361
- Filed
- Jan 7, 2022
- Trade date
- Jan 4-5, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $1.62M. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Power Sean ACIK 0001538845 | Officer (CFO, Secretary and Treasurer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2022 | COMMON STOCK | SSaleDisposed | −75,312 | $19.20 | −$1,445,990.4 | 578,136 | Direct | |
| Jan 5, 2022 | COMMON STOCK | SSaleDisposed | −9,653 | $18.31 | −$176,746.43 | 568,483 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.